RegenExtracell BMC & GLUE achieve recovery rates from bone marrow aspirate of 74% of MNC’s and 87% of MSC’s. 6 RegenExtracell BMC & GLUE were shown to result in successful healing rates for bone defects in the range of 79% to 100% with healing times as short as 2.5 months. . RegenExtracell® BMC . BMC Protocol . RegenExtracell Adipocytes . Adipocytes Protocol . RegenExtracell® BMC Qualified as a “one-step” technology, RegenExtracell BMC allows the extemporaneous concentration of bone marrow Stem Cells aspirate, which is immediately followed by its re-implantation (same surgical procedure). The bone marrow is known to be rich in a heterogeneous population of mature and pluripotent stem cells (BMC’s: Bone Marrow Stem Cells). The bone marrow microenvironment, or medullary stroma, harbours, in addition to the well known blood cell progenitors (hematopoietic stem cells, HSCs), various immature cells such as mesenchymal stem cells (MSC’s, which are the musculoskeletal cell precursors), pre-adipocytes, endothelial progenitor cells, etc. The heterogeneous nature of the bone marrow cellular microenvironment results in a very high regenerative potential, especially for bone and osteochondral tissues.